Not finding it? Sign in to also search OpenAlex live.
-
[18F]FDG-PET accurately identifies pathological response early upon neoadjuvant immune checkpoint blockade in head and neck squamous cell carcinoma2021 European Journal of Nuclear Medicine and Molecular Imaging article Medicine Medical Imaging Techniques and Applications Open access
Joris L. Vos, Charlotte L. Zuur, Laura A. Smit, Jan Paul de Boer, Abrahim A. Al-Mamgani, Michiel W. M. van den Brekel, +2 more
42citations -
89Zr-Trastuzumab PET/CT Imaging of HER2-Positive Breast Cancer for Predicting Pathological Complete Response after Neoadjuvant Systemic Therapy: A Feasibility Study
Daan G. J. Linders, Marion M. Deken, Martijn A. van Dam, Martin N.J.M. Wasser, Eleonora M. C. Voormolen, Judith R. Kroep, +13 more
17citations -
Tumor‐stroma ratio is associated with Miller‐Payne score and pathological response to neoadjuvant chemotherapy in HER2 ‐negative early breast cancer2021 International Journal of Cancer article Biochemistry, Genetics and Molecular Biology Breast Cancer Treatment Studies Open access
Sophie C. Hagenaars, Stefanie de Groot, Danielle B. Cohen, Tim J. A. Dekker, Ayoub Charehbili, Elma Meershoek‐Klein Kranenbarg, +6 more
43citations -
Clinical, pathological and molecular characteristics of patients with disease recurrence despite pathologic response to neoadjuvant ipilimumab plus nivolumab in stage III melanoma
Judith M. Versluis, Huma Shehwana, Robert Elens, Alexander Maxwell Menzies, Irene L. M. Reijers, Petros Dimitriadis, +10 more
5citations -
Oncological outcomes after a pathological complete response following total neoadjuvant therapy or chemoradiotherapy for high-risk locally advanced rectal cancer in the RAPIDO trial
W.H. Zwart, Sofieke J. D. Temmink, Geke A.P. Hospers, Corrie A.M. Marijnen, Hein Putter, Irıs D. Nagtegaal, +9 more
43citations -
Predictors of- and oncological outcomes after a pathological complete response following total neoadjuvant treatment or chemoradiotherapy for locally advanced rectal cancer in the RAPIDO trial
Sofieke J. D. Temmink, W.H. Zwart, Geke A.P. Hospers, Corrie A.M. Marijnen, Bengt L. G. Glimelius, Cornelis J.�H. van de Velde, +3 more
0citations -
Retinal vessel analysis to assess microvascular function in the healthy eye: A systematic review on the response to acute physiological and pathological stressors
Jan Van Eijgen, Lien Van Winckel, Henner Hanssen, Konstantin E. Kotliar, Thomas Vanassche, Emeline M. Van Craenenbroeck, +4 more
11citations -
A review of the association between baseline [18F] fluorodeoxyglucose uptake and axillary pathological complete response in node-positive breast cancer patients: focus on clinical subtypes2025 Nuclear Medicine Communications article Biochemistry, Genetics and Molecular Biology Breast Cancer Treatment Studies Open access
Melissa Lenaerts, Florien J G van Amstel, Felix Manuel Mottaghy, Sandra M. E. Geurts, Vivianne C. G. Tjan‐Heijnen, Marjolein L. Smidt, +1 more
6citations -
Tumor-stroma ratio is associated with Miller-Payne and pathological response to neoadjuvant chemotherapy in HER2-negative early breast cancer2020 European Journal of Cancer article Biochemistry, Genetics and Molecular Biology Breast Cancer Treatment Studies
Sophie C. Hagenaars, S de Groot, Danielle B. Cohen, Ayoub Charehbili, Tim J. A. Dekker, Elma Meershoek‐Klein Kranenbarg, +6 more
3citations -
Oncological Outcomes after a Pathological Complete Response Following Total Neoadjuvant Therapy or Chemoradiotherapy for High-Risk Locally Advanced Rectal Cancer in the RAPIDO Trial
W.H. Zwart, Sofieke J. D. Temmink, Geke A.P. Hospers, Corrie A.M. Marijnen, H. Putter, Irıs D. Nagtegaal, +9 more
2citations -
1683TiP OMIT trial: omitting therapeutic lymph node dissection in patients with stage IIIB/C melanoma and major pathological response in the index lymph node after neoadjuvant immunotherapy
Antonius W Schurink, Evalyn E.A.P. Mulder, Lukas B. Been, James van Bastelaar, Han J. Bonenkamp, Anneriet E. Dassen, +10 more
1citations -
Tumour-stroma ratio is associated with Miller-Payne grading system and pathological response to neoadjuvant chemotherapy in HER2-negative breast cancer2021 European Journal of Surgical Oncology article Biochemistry, Genetics and Molecular Biology Breast Cancer Treatment Studies
Sophie C. Hagenaars, Stefanie de Groot, Danielle B. Cohen, Tim J. A. Dekker, Marjolijn Duijm‐de Carpentier, Ayoub Charehbili, +6 more
0citations -
Corrigendum to “Pathological chemotherapy response score is prognostic in tubo-ovarian high-grade serous carcinoma: A systematic review and meta-analysis of individual patient data” [Gynecol. Oncol. 154 (2019) 441–448]
Paul Andrew Cohen, Aime Powell, C. Blake Gilks, Colin J.R. Stewart, Tarek M. Meniawy, Max Kishor Bulsara, +22 more
2citations -
Corrigendum to “Pathological chemotherapy response score is prognostic in tubo-ovarian high-grade serous carcinoma: A systematic review and meta-analysis of individual patient data” Gynecol. Oncol. 154 (2019) 441–448
Paul Andrew Cohen, Aime Powell, C. Blake Gilks, Colin J.R. Stewart, Tarek M. Meniawy, Max Kishor Bulsara, +22 more
0citations -
Early response by MR imaging and ultrasound as predictor of pathologic complete response to 12‐week neoadjuvant therapy for different early breast cancer subtypes: Combined analysis from the WSG ADAPT subtrials
Monika Graeser, Simone Schrading, Oleg Gluz, Kevin Strobel, Rachel Würstlein, Sherko Kümmel, +15 more
12citations -
Personalized response-directed surgery and adjuvant therapy after neoadjuvant ipilimumab and nivolumab in high-risk stage III melanoma: the PRADO trial
Irene L. M. Reijers, Alexander Maxwell Menzies, Alexander C. J. van Akkooi, Judith M. Versluis, N.M.J. Van Den Heuvel, Robyn P.M. Saw, +31 more
378citations -
6P Response and survival according to the interferon-gamma (IFN-γ) signature and tumor mutational burden (tmb) in the PRADO trial testing neoadjuvant ipilimumab and nivolumab in stage III melanoma
Reijers, P. Dimitriadis, J.J. Traets, Robyn P.M. Saw, J.M. Versluis, Thomas E. Pennington, +14 more
4citations -
Prediction of Primary Tumour and Axillary Lymph Node Response to Neoadjuvant Chemo(Targeted) Therapy with Dedicated Breast [18F]FDG PET/MRI in Breast Cancer
Cornelis Maarten de Mooij, Thiemo J. A. van Nijnatten, Briete Goorts, Loes F. S. Kooreman, Isabel W. M. Raymakers, Silke P. L. van Meijl, +6 more
12citations -
The impact of emotional distress on pathologic response and survival after neoadjuvant combination immune checkpoint blockade (ICB) in high-risk stage III melanoma.2023 Journal of Clinical Oncology conference-abstract Medicine Cancer Immunotherapy and Biomarkers Open access
Irene L. M. Reijers, Itske Fraterman, Petros Dimitriadis, Annegien Broeks, Maria Gonzalez, Alexander Maxwell Menzies, +7 more
3citations